CONMED (CNMD) vs LivaNova (LIVN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
LivaNova (LIVN) has outperformed CONMED (CNMD) over the past year, gaining 46.6% versus a loss of 2.2%. Over five years, LIVN leads with a -8.9% price change compared with -68.7% for CNMD. LivaNova is the larger company by market cap ($4.20 billion vs $1.33 billion), about 3.2 times the size.
On valuation, CONMED trades at a lower forward P/E (9.3x vs 16.3x for LivaNova). CONMED pays a dividend yielding 0.45%, while LivaNova does not currently pay one. CONMED converts more of its revenue into profit, with a net margin of 3.4% versus -17.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNMD | LIVN |
|---|---|---|
| Share price | $44.42 | $76.39 |
| Market cap | $1.33B | $4.20B |
| 1-day change | -1.53% | +0.63% |
| YTD return | +9.41% | +24.15% |
| 1-year return | -2.18% | +46.59% |
| 5-year return | -68.72% | -8.94% |
| P/E ratio (TTM) | 24.01 | 22.60 |
| Forward P/E | 9.29 | 16.31 |
| EPS (TTM) | $1.85 | $3.38 |
| Dividend yield | 0.45% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| Revenue (latest FY) | $1.37B | $1.39B |
| Revenue growth (YoY) | +5.18% | +10.74% |
| Net income (latest FY) | $47.05M | $-242.47M |
| Gross margin | 54.59% | 67.71% |
| Operating margin | 7.46% | 14.36% |
| Net margin | 3.42% | -17.47% |
| 52-week high | $53.66 | $85.76 |
| 52-week low | $31.44 | $48.82 |
| Distance from 52-week high | -17.22% | -10.93% |
| Analyst consensus | none | buy |
| Avg. price target upside | +2.43% | +18.54% |
| Average volume | 482.58K | 648.38K |
| Shares outstanding | 29.95M | 54.93M |
| Employees | 3,900 | 3,300 |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LivaNova is about 3.2 times larger than CONMED by market value ($4.20B vs $1.33B).
- LIVN has outperformed CNMD by 48.8 percentage points over the past year.
- CONMED is more profitable, keeping 3.4 cents of every revenue dollar as net income versus -17.5 cents for LivaNova.
- LivaNova grew revenue faster in its latest fiscal year (+10.74% vs +5.18%).
- The two companies sit in different sectors: CONMED in Healthcare and LivaNova in Health Care.
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as powered resection instruments, fluid management and visualization systems, and related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Healthcare · Medical Devices · 3,900 employees
About LivaNova
LIVN stock →LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,300 employees
CNMD vs LIVN FAQ
Which is bigger, CONMED or LivaNova?
LivaNova (LIVN) is larger, with a market capitalization of $4.20B compared with $1.33B for CONMED (CNMD).
Which stock has performed better over the past year, CNMD or LIVN?
LIVN returned +46.59% over the past 12 months, compared with -2.18% for CNMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CNMD or LIVN?
LIVN has the lower trailing P/E at 22.6, versus 24.0 for CNMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, CONMED or LivaNova?
CONMED pays a dividend yielding 0.45%, while LivaNova does not currently pay a regular dividend.
Are CONMED and LivaNova in the same industry?
No. CONMED is in the Healthcare sector, while LivaNova is in Health Care.